Illumina, Inc., is a biotechnology company based in San Diego, California, that operates in over 140 countries. Established in 1998, Illumina specializes in the creation, production, and distribution of integrated systems used in the examination of genetic diversity and biological processes.
At the moment, talks of the US debt ceiling are creating cautious markets and summer months tend to be weaker for most major indices. However, is Illumina able to shine in the summer months with its impressive summer seasonal pattern? Over the last 10 years, Illumina shares have gained 80% of the time between May 23 and August 2. The maximum gain has been over 23% and the drawdown has been relatively mild, but there was a large drop last year of nearly 30%.
Major Trade Risks: The biggest risk here is if the US debt ceiling talks fail, this will likely sharply weaken US stocks.
